EA199900757A1 - Фармацевтические композиции - Google Patents

Фармацевтические композиции

Info

Publication number
EA199900757A1
EA199900757A1 EA199900757A EA199900757A EA199900757A1 EA 199900757 A1 EA199900757 A1 EA 199900757A1 EA 199900757 A EA199900757 A EA 199900757A EA 199900757 A EA199900757 A EA 199900757A EA 199900757 A1 EA199900757 A1 EA 199900757A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
thiacytidine
oxathiolan
epivir
lamivudine
Prior art date
Application number
EA199900757A
Other languages
English (en)
Other versions
EA001990B1 (ru
Inventor
Нгок-Анх Тхи Нгуен
Уоррен Майкл Кэйзи
Original Assignee
Глаксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Глаксо Груп Лимитед filed Critical Глаксо Груп Лимитед
Publication of EA199900757A1 publication Critical patent/EA199900757A1/ru
Publication of EA001990B1 publication Critical patent/EA001990B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Данное изобретение относится к новым фармацевтическим препаратам, содержащим (2R,цис)-4-амино-1-(2-гидроксиметил-1,3-оксатиолан-5-ил)-(1Н)-пиримидин-2-он ((-)-2',3'-дидезокси,3'-тиацитидин, Epivir, ламивудин), и их применению в терапевтическом лечении.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900757A 1997-03-24 1998-03-20 Фармацевтические композиции EA001990B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation
PCT/EP1998/001626 WO1998042321A2 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine

Publications (2)

Publication Number Publication Date
EA199900757A1 true EA199900757A1 (ru) 2000-08-28
EA001990B1 EA001990B1 (ru) 2001-10-22

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900757A EA001990B1 (ru) 1997-03-24 1998-03-20 Фармацевтические композиции

Country Status (40)

Country Link
US (1) US6004968A (ru)
EP (1) EP0969815B1 (ru)
JP (1) JP3264937B2 (ru)
KR (1) KR100484695B1 (ru)
CN (1) CN1191061C (ru)
AP (1) AP1141A (ru)
AR (1) AR011697A1 (ru)
AT (1) ATE295150T1 (ru)
AU (1) AU728461B2 (ru)
BG (1) BG64690B1 (ru)
BR (1) BR9808060B1 (ru)
CA (1) CA2286126C (ru)
CO (1) CO4980849A1 (ru)
CY (1) CY2569B1 (ru)
CZ (1) CZ298008B6 (ru)
DE (1) DE69830154T2 (ru)
EA (1) EA001990B1 (ru)
EE (1) EE03996B1 (ru)
ES (1) ES2239802T3 (ru)
HK (1) HK1022853A1 (ru)
HN (1) HN1998000045A (ru)
HR (1) HRP980154B1 (ru)
HU (1) HU225600B1 (ru)
ID (1) ID29294A (ru)
IL (1) IL131917A0 (ru)
IS (1) IS2515B (ru)
MY (1) MY116242A (ru)
NO (1) NO326719B1 (ru)
NZ (1) NZ337798A (ru)
PA (1) PA8449301A1 (ru)
PE (1) PE61699A1 (ru)
PL (1) PL190505B1 (ru)
PT (1) PT969815E (ru)
RS (1) RS49772B (ru)
SI (1) SI0969815T1 (ru)
SK (1) SK283417B6 (ru)
SV (1) SV1998000040A (ru)
TW (1) TW536403B (ru)
UY (1) UY24930A1 (ru)
WO (1) WO1998042321A2 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID19490A (id) 1996-06-25 1998-07-16 Glaxo Group Ltd Kombinasi-kombinasi antiviral
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
JP4607010B2 (ja) * 2003-02-28 2011-01-05 中外製薬株式会社 タンパク質含有安定化製剤
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
AU1787492A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
NO326719B1 (no) 2009-02-02
CA2286126A1 (en) 1998-10-01
ES2239802T3 (es) 2005-10-01
SV1998000040A (es) 1999-03-16
PA8449301A1 (es) 2000-05-24
EP0969815B1 (en) 2005-05-11
UY24930A1 (es) 2000-10-31
PT969815E (pt) 2005-07-29
HRP980154B1 (en) 2002-06-30
ID29294A (id) 2001-08-16
BR9808060A (pt) 2000-03-08
BR9808060B1 (pt) 2009-05-05
IL131917A0 (en) 2001-03-19
JP2001501974A (ja) 2001-02-13
CO4980849A1 (es) 2000-11-27
DE69830154D1 (de) 2005-06-16
PL190505B1 (pl) 2005-12-30
MY116242A (en) 2003-12-31
EA001990B1 (ru) 2001-10-22
AP1141A (en) 2003-01-29
JP3264937B2 (ja) 2002-03-11
KR100484695B1 (ko) 2005-04-22
IS2515B (is) 2009-06-15
KR20010005624A (ko) 2001-01-15
HUP0002982A3 (en) 2001-12-28
SK283417B6 (sk) 2003-07-01
HK1022853A1 (en) 2000-08-25
PE61699A1 (es) 1999-07-08
AU728461B2 (en) 2001-01-11
DE69830154T2 (de) 2005-10-13
HU225600B1 (en) 2007-05-02
NZ337798A (en) 2001-03-30
CZ340399A3 (cs) 2000-04-12
EP0969815A2 (en) 2000-01-12
TW536403B (en) 2003-06-11
BG103818A (en) 2000-06-30
EE9900440A (et) 2000-04-17
HN1998000045A (es) 1999-03-19
NO994619D0 (no) 1999-09-23
CZ298008B6 (cs) 2007-05-23
NO994619L (no) 1999-11-23
US6004968A (en) 1999-12-21
IS5184A (is) 1999-09-17
CN1191061C (zh) 2005-03-02
WO1998042321A2 (en) 1998-10-01
WO1998042321A3 (en) 1999-01-07
YU47799A (sh) 2002-06-19
SI0969815T1 (ru) 2005-08-31
CN1255849A (zh) 2000-06-07
HUP0002982A2 (hu) 2001-01-29
CY2569B1 (en) 2008-07-02
SK129999A3 (en) 2000-07-11
AR011697A1 (es) 2000-08-30
HRP980154A2 (en) 1998-12-31
AU7208498A (en) 1998-10-20
IL131917A (en) 2001-01-11
RS49772B (sr) 2008-06-05
EE03996B1 (et) 2003-04-15
AP9901657A0 (en) 1999-09-30
BG64690B1 (bg) 2005-12-30
PL336038A1 (en) 2000-06-05
ATE295150T1 (de) 2005-05-15
CA2286126C (en) 2003-08-12

Similar Documents

Publication Publication Date Title
EA199700203A1 (ru) Синергические комбинации зидовудина, 1592u89 и 3тс или ftc
NZ238017A (en) (-)-cis-4-amino-1 -(2-hydroxymethyl -1,3-oxathiolan-5-yl) -(1h)- pyrimidin-2-one, preparation and pharmaceutical compositions
RU94013464A (ru) Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции
YU74992A (sh) Postupak za pravljenje (-)4-amino-5-fluoro-1-(2-hidroksimetil-1,3-oksatiolan-5-il)-(1h)-pirimidin-2-ona
EA199900757A1 (ru) Фармацевтические композиции
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
EA200400962A1 (ru) Полиалкиленгликоль с остатком для конъюгации биологически активного соединения
DE69119074T2 (de) Kovalente-ther lipidnukleosid-konjugate
ATE231872T1 (de) Thiazolopyrimidinderivate
EA199801045A1 (ru) Комбинации, содержащие vx478, зидовудин, ftc и/или 3тс, для применения при лечении вич
DE60313657D1 (de) Antivirale zusammensetzungen
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
WO2001030329A3 (en) Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction
ECSP982450A (es) Composiciones farmaceuticas
EA200400764A1 (ru) 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение
FR2798287B1 (fr) Composition cosmetique riche en nacres, contenant une charge synthetique absorbante
ATE112288T1 (de) Vinylsulfonyl pristinamycine und deren herstellung.
AR007616A1 (es) Combinaciones antivirales
ES1048574U (es) Conmutador-interruptor perfeccionado.

Legal Events

Date Code Title Description
MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM RU